Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 6
- +1 vs. Q4 2024
- Portfolio value
- $132.7M
- −$6.52M (−4.7%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IMNMImmunome Inc. | COM | 4,768,583 | $32.1M | 24.2% | +1,290,322+37.1% | Added | History |
| ZBIOZenas BioPharma, Inc. | COM | 3,761,359 | $29.7M | 22.4% | 00.0% | Unchanged | History |
| SIONSionna Therapeutics, Inc. | COM | 2,478,030 | $25.9M | 19.5% | +2,478,030 | New | History |
| CAMPCamp4 Therapeutics Corp | COM | 3,785,802 | $15.1M | 11.4% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 2,459,703 | $15.1M | 11.3% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 7,788,150 | $14.8M | 11.1% | 00.0% | Unchanged | History |